Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-3-25
|
pubmed:abstractText |
A retrospective review was done on all high volume choriocarcinomas and other germ cell tumors of men with serum beta-human chorionic gonadotropin (beta-HCG) levels greater than 50,000 mIU/ml to determine the incidence and characteristics of hyperthyroidism in this setting. Nineteen patients were identified with high beta-HCG levels, but because 2 did not have thyroid function tests performed, the cases of only 17 patients were evaluable. Of these, 14 (82%) had primary testicular carcinoma and 3 (18%) had extragonadal tumors. Beta-HCG levels on presentation ranged from 80,000 to 3,058,000 mIU/ml, with a median of 243,500 mIU/ml. Seven of the 17 evaluable cases (41%) had T4 serum levels higher than 12 micrograms/dl (normal level 4 to 12 micrograms/dl) with a median value of 15.4 micrograms/dl (range, 12.6 to 33.5 micrograms/dl); serum T4 levels correlated with beta-HCG levels (r = 0.84). All seven patients with elevated T4 levels had beta-HCG values greater than 200,000 mIU/ml, and three of these seven had clinical manifestations that could be attributed to an elevated serum T4; only one patient required specific antithyroid treatment; and after control of primary disease, all other patients had normalization of thyroid function. The most common manifestations of hyperthyroidism in our series were tachycardia, hypertension, and a systolic flow murmur; none of the patients had thyroid gland enlargement. We conclude that subclinical hyperthyroidism is a relatively common phenomenon in germ cell tumors of men with high levels of beta-HCG and that control of the primary disease results in serum T4 level normalization.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1286-90
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1371235-Adolescent,
pubmed-meshheading:1371235-Adult,
pubmed-meshheading:1371235-Choriocarcinoma,
pubmed-meshheading:1371235-Chorionic Gonadotropin,
pubmed-meshheading:1371235-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:1371235-Humans,
pubmed-meshheading:1371235-Hyperthyroidism,
pubmed-meshheading:1371235-Incidence,
pubmed-meshheading:1371235-Male,
pubmed-meshheading:1371235-Middle Aged,
pubmed-meshheading:1371235-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:1371235-Peptide Fragments,
pubmed-meshheading:1371235-Retrospective Studies,
pubmed-meshheading:1371235-Testicular Neoplasms,
pubmed-meshheading:1371235-Thyroxine
|
pubmed:year |
1992
|
pubmed:articleTitle |
Hyperthyroidism in men with germ cell tumors and high levels of beta-human chorionic gonadotropin.
|
pubmed:affiliation |
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
|
pubmed:publicationType |
Journal Article
|